JENNIFER SNIPES: Open Payments
NPI 1043658198 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,843 in 95 payments from 19 companies in 2025. Trend: 2023 $3,052 · 2024 $3,447 · 2025 $1,843
Food & beverage: $1,677Education: $166
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 18 | $278 |
| Janssen Biotech, Inc. | 12 | $230 |
| Regeneron Healthcare Solutions, Inc. | 12 | $199 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $140 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| Amgen Inc. | 6 | $119 |
| Incyte Corporation | 6 | $114 |
| Organon LLC | 5 | $109 |
| LEO Pharma Inc. | 5 | $96 |
| Arcutis Biotherapeutics, Inc. | 5 | $96 |
Products named: NEMLUVIO, TREMFYA, DUPIXENT, OTEZLA, OPZELURA, Zoryve, ADBRY, COSENTYX.
Industry payments across TX — which companies pay providers there.
